Literature DB >> 19449234

Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.

A Server1, B Kulle, J Maehlen, R Josefsen, T Schellhorn, T Kumar, C W Langberg, P H Nakstad.   

Abstract

BACKGROUND: Conventional magnetic resonance (MR) imaging has a number of limitations in the diagnosis of the most common intracranial brain tumors, including tumor specification and the detection of tumoral infiltration in regions of peritumoral edema.
PURPOSE: To prospectively assess if diffusion-weighted MR imaging (DWI) could be used to differentiate between different types of brain tumors and to distinguish between peritumoral infiltration in high-grade gliomas, lymphomas, and pure vasogenic edema in metastases and meningiomas.
MATERIAL AND METHODS: MR imaging and DWI was performed on 93 patients with newly diagnosed brain tumors: 59 patients had histologically verified high-grade gliomas (37 glioblastomas multiforme, 22 anaplastic astrocytomas), 23 patients had metastatic brain tumors, five patients had primary cerebral lymphomas, and six patients had meningiomas. Apparent diffusion coefficient (ADC) values of tumor (enhancing regions or the solid portion of tumor) and peritumoral edema, and ADC ratios (ADC of tumor or peritumoral edema to ADC of contralateral white matter, ADC of tumor to ADC of peritumoral edema) were compared with the histologic diagnosis. ADC values and ratios of high-grade gliomas, primary cerebral lymphomas, metastases, and meningiomas were compared by using ANOVA and multiple comparisons. Optimal thresholds of ADC values and ADC ratios for distinguishing high-grade gliomas from metastases were determined by receiver operating characteristic (ROC) curve analysis.
RESULTS: Statistically significant differences were found for minimum and mean of ADC tumor and ADC tumor ratio values between metastases and high-grade gliomas when including only one factor at a time. Including a combination of in total four parameters (mean ADC tumor, and minimum, maximum and mean ADC tumor ratio) resulted in sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of 72.9, 82.6, 91.5, and 54.3% respectively. In the ROC curve analysis, the area under the curve of the combined four parameters was the largest (0.84), indicating a good test.
CONCLUSION: Our results suggest that ADC values and ADC ratios (minimum and mean of ADC tumor and ADC tumor ratio) may be helpful in the differentiation of metastases from high-grade gliomas. It cannot distinguish high-grade gliomas from lymphomas, and lymphomas from metastases. ADC values and ADC ratios in peritumoral edema cannot be used to differentiate edema with infiltration of tumor cells from vasogenic edema when measurements for high-grade gliomas, lymphomas, metastases, and meningiomas were compared.

Entities:  

Mesh:

Year:  2009        PMID: 19449234     DOI: 10.1080/02841850902933123

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  38 in total

1.  Bevacizumab: radiation combination produces restricted diffusion on brain MRI.

Authors:  John R Hesselink; Matthew J Barkovich; Tyler M Seibert; Nikdokht Farid; Karra A Muller; Kevin T Murphy; Santosh Kesari
Journal:  CNS Oncol       Date:  2014

2.  Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors.

Authors:  J L Jaremko; L B O Jans; L T Coleman; M R Ditchfield
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-10       Impact factor: 3.825

3.  Diffusion-Weighted Imaging for Predicting and Monitoring Primary Central Nervous System Lymphoma Treatment Response.

Authors:  W-Y Huang; J-B Wen; G Wu; B Yin; J-J Li; D-Y Geng
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-07       Impact factor: 3.825

4.  Three-dimensional simultaneous brain T1 , T2 , and ADC mapping with MR Multitasking.

Authors:  Sen Ma; Christopher T Nguyen; Fei Han; Nan Wang; Zixin Deng; Nader Binesh; Franklin G Moser; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2019-11-25       Impact factor: 4.668

5.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

6.  Diagnostic performance of DWI for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis.

Authors:  Xiaoyang Lu; Weilin Xu; Yuyu Wei; Tao Li; Liansheng Gao; Xiongjie Fu; Yuan Yao; Lin Wang
Journal:  Neurol Sci       Date:  2019-01-31       Impact factor: 3.307

7.  Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences.

Authors:  S Gaudino; G M Di Lella; R Russo; V S Lo Russo; F Piludu; F R Quaglio; M R Gualano; C De Waure; C Colosimo
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

8.  Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value.

Authors:  Ching-Chung Ko; Sher-Wei Lim; Tai-Yuan Chen; Jeon-Hor Chen; Chien-Feng Li; Yow-Ling Shiue
Journal:  J Neurooncol       Date:  2018-01-20       Impact factor: 4.130

9.  Neuromorphometry of primary brain tumors by magnetic resonance imaging.

Authors:  Nidiyare Hevia-Montiel; Pedro I Rodriguez-Perez; Paul J Lamothe-Molina; Alfonso Arellano-Reynoso; Ernesto Bribiesca; Marco A Alegria-Loyola
Journal:  J Med Imaging (Bellingham)       Date:  2015-05-12

Review 10.  Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature.

Authors:  Hector N Aguilar; Ryan W Hung; Vivek Mehta; Trevor Kotylak
Journal:  J Radiol Case Rep       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.